Author

Kelly SY Lim

South Australian Health and Medical Research InstituteORCID 0000-0003-4606-7588Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Agnes S. M. YongiD· 1 shared BeiJun CheniD· 1 shared Charles T. H. ChuahiD· 1 shared Chung Hoow KokiD· 1 shared Cong M Pham· 1 shared Danièl ThomasiD· 1 shared David M. RossiD· 1 shared David T. O. YeungiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agnes S. M. YongORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 15, 2025

Mitochondrial DNA Mutations Determine Favourable Molecular Responses to Targeted Kinase Inhibitor Therapy and Impair Oxidative Phosphorylation

Ilaria Stefania Pagani, Vaidehi Krishnan, John F. Ouyang…·David M. Ross

This study shows that mitochondrial DNA mutations are linked to better responses to kinase inhibitor therapy and reduced oxidative phosphorylation in CML patients.

DOI 10.1101/2025.07.15.664865

humanbulk RNA-seq

𝕏 PostBluesky